Skip to search formSkip to main contentSkip to account menu

OVCAR-3

An adenocarcinoma cell line established from a 60 year old Caucasian female patient with ovarian carcinoma previously treated with chemotherapy.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes
A method for synthesizing superparamagnetic iron oxide (SPIO) multi-nanoparticle aggregates as molecular magnetic resonance… 
Highly Cited
2006
Highly Cited
2006
Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
2005
2005
211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
UNLABELLED The use of alpha-particle emitters in radioimmunotherapy (RIT) appears to be promising. We previously obtained… 
Highly Cited
2003
Highly Cited
2003
beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.
Highly Cited
2001
Highly Cited
2001
Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
S 23906-1 is a novel acronycine derivative selected on the basis of its potency in vitro. We investigated the antitumor activity… 
Highly Cited
1995
Highly Cited
1995
Chemotherapy‐Induced Apoptosis in Epithelial Ovarian Cancers
Highly Cited
1994
Highly Cited
1994
Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells
Highly Cited
1993
Highly Cited
1993
Calcium mobilization and cell proliferation activated by extracellular ATP in human ovarian tumour cells.
Highly Cited
1992
Highly Cited
1992
The human IGF-I gene contains two cell type-specifically regulated promoters.
1990
1990
Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescence.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)